SMEFX
Price
$21.04
Change
+$0.09 (+0.43%)
Updated
Jul 31 closing price
Net Assets
1.14B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

SMEFX vs VSCIX

SMEFX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
SMEFX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMEFX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. SMEFX (1.14B). VSCIX pays higher dividends than SMEFX: VSCIX (1.23) vs SMEFX (0.00). SMEFX was incepted earlier than VSCIX: SMEFX (14 years) vs VSCIX (29 years). SMEFX (0.82) is less costly to investors than VSCIX (0.03). SMEFX is a more actively managed with annual turnover of: 60.00 vs. VSCIX (17.00). SMEFX has a lower initial minimum investment than VSCIX: SMEFX (1000000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. SMEFX (11.91). VSCIX return over 5 years is better than : 35.13 vs. SMEFX (2.60).
SMEFXVSCIXSMEFX / VSCIX
Total Expense Ratio0.820.032,733%
Annual Report Gross Expense Ratio0.820.032,733%
Fund Existence14 years29 years-
Gain YTD14.97314.591103%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B189B1%
Annual Yield % from dividends0.001.23-
Returns for 1 year11.9122.5853%
Returns for 3 years32.0843.4474%
Returns for 5 years2.6035.137%
Returns for 10 years40.41156.0726%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C